NAME    
Brian Lincoln Shaffer MD    
DATE    
3/18/2022

PRESENT POSITION AND ADDRESS
    
Department/Division:
    Director, Prenatal Diagnosis Center; Attending Physician
Obstetrics and Gynecology/Maternal-Fetal Medicine/Medical Genetics
Sutter West Bay Medical Group

Professional Address:    1100 Van Ness Ave, 4th Floor
San Francisco, CA 94109

E-Mail Address:    
shaffebl@sutterhealth.org

    
II.  EDUCATION
Undergraduate and Graduate (Year/Degree/Institution):
        1992-96    BA/Columbia University, New York, NY     
            1997-01    MD/ Medical College of Pennsylvania-Hahnemann SOM

Postgraduate (Year/Degree/Institution):
2001-04     UC San Francisco        Resident     Obstetrics and Gynecology
2004-05     UC San Francisco          Chief Resident    Obstetrics and Gynecology
2005-09    UC San Francisco         Fellow         Maternal-Fetal Medicine
2007-09    UC San Francisco        Fellow        Medical Genetics

Certification (Board/Number/Date/Recertification):    
  2007     ABOG Obstetrics and Gynecology Board Certification, Diplomate #9011601
  2009    ABMG American Board of Medical Genetics, Certificate Number 2009139
  2012    ABOG Maternal Fetal Medicine Board Certification, Diplomate #9011601

Licenses (State/Date/Status/Number/Renewal Date):
         2010        Medical License, Oregon #MD153180 - Inactive
         2020    Medical License, California #A82583

III. PROFESSIONAL EXPERIENCE
Academic (Year/Position/Institution):
       2020-Present       Director, Prenatal Diagnosis Center, Attending Physician, SWBMG
       2016-2020               Associate Professor-Maternal-Fetal Medicine, Dept. ObGyn; OHSU
       2016-2020           Joint appointment Associate Professor, Diagnostic Radiology, OHSU
       2016-2020           Joint appointment Associate Professor, Pediatrics, Division of Neonatology
       2010-2016           Assistant Professor-Maternal-Fetal Medicine, Dept. ObGyn; OHSU
       2015-2016             Joint appointment Assistant Professor, Diagnostic Radiology, OHSU
       2011-2016             Joint appointment Assistant Professor, Pediatrics, Division of Neonatology
       2009-2010          Assistant Professor, Perinatal Medicine and Genetics, Dept. ObGyn & RS; UCSF
       2005-2007        Clinical Instructor WOS, Obstetrics, Gynecology & Reproductive Sciences, UCSF

Administrative (Year/Position/Institution):
       2020-Present     Prenatal Diagnosis Center, Director SWBMG
       2018-2020       Program Director, Maternal Fetal Medicine Fellowship
       2016-2018               Assistant Program Director, Maternal Fetal Medicine Fellowship
       2012- 2020     Director, Prenatal Diagnosis Program, OHSU
       2011- 2020     Director, Doernbecher Fetal Therapy Program, OHSU
       2011- 2017     Member QEC Committee Obstetrics, OHSU

Other (Year/Position/Institution):
       2015         OHSU Pathways to Leadership
Nominated by Departmental leadership Coursework focused attaining on the skills necessary to further leadership development at OHSU.  Course Directors – Jim Huntzicker & Niki Steckler 
       2010-2011        Group Moderator, SMFM Communities, Society of Maternal Fetal Medicine

IV. SCHOLARSHIP
Peer-reviewed 
Articles: Original Research
1)    Cheng YW, Shaffer BL, Caughey AB. Associated factors and outcomes of persistent occiput posterior position. J Mat Fet Med 2006;19:563-568.
2)    Cheng YW, Shaffer BL, Caughey AB. Neonatal Outcomes Associated with Occiput Posterior Position. Obstet Gynecol, 2006;107:837-844.
3)    Shaffer BL, Cheng YW, Vargas J, Laros RK Jr, Caughey AB. Face Presentation: Predictors and Delivery Route. Am J Obstet Gynecol 2006;194:e10-12.  
4)    Shaffer BL, Cheng YW, Vargas J, Laros RK Jr, Caughey AB. Manual Rotation of the Fetal Occiput: Predictors of Success and Delivery. Am J Obstet Gynecol 2006;194:e7-e9.
5)    Bianco K, Caughey AB, Davis R, Shaffer BL, Norton ME. History of miscarriage and increased incidence of fetal aneuploidy in subsequent pregnancy. Obstet Gynecol 2006;107:1098-1102.
6)    Shaffer BL, Caughey AB, Norton ME. Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Prenat Diagn 2006;26:667-671.
7)    Kaimal AJ, Cheng YW, Bryant AS, Norton ME, Shaffer BL, Caughey AB. Google obstetrics: who is educating our patients? Am J Obstet Gynecol. 2008;198:e1-5.
8)    Henry DE Cheng YW, Shaffer BL, Kaimal AJ, Bianco K, Caughey AB. Perinatal outcomes in the setting of active phase arrest of labor. Obstet Gynecol. 2008;112:1109-15
9)    Caughey AB, Sundaram V, Kaimal AJ, Cheng YW, Gienger A, Little SE, Lee JF, Wong L, Shaffer BL, Tran SH, Padula A, McDonald KM, Long EF, Owens DK, Bravata DM. Maternal and neonatal outcomes of elective induction of labor. Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257.
10)    Caughey AB, Sundaram V, Kaimal AJ, Gienger A, Cheng YW, McDonald KM, Shaffer BL, Owens DK, Bravata DM. Systematic review: elective induction of labor versus expectant management of pregnancy. Ann Intern Med 2009;18:252-63
11)    Jelin AC, Cheng YW, Shaffer BL, Kaimal AJ, Little SE, Caughey AB. Early onset preeclampsia and neonatal outcomes. J Matern Fetal Neo Med 2010;23:389-92.
12)    Delaney S, Shaffer BL, Cheng YW, Vargas JE, Sparks T, Paul K, Caughey AB. Labor induction with a foley balloon inflated to 30mL compared with 60mL: a randomized controlled trial. Obstet Gynecol 2010115:1239-45.
13)    Cheng YW, Shaffer BL, Bryant AS, Caughey AB. Length of the first stage of labor and associated perinatal outcomes in nulliparous women. Obstet Gynecol 2010;116:1127-35.
14)    Shaffer BL, Cheng YW, Vargas JE, Caughey AB. Manual Rotation to Reduce Cesarean Delivery in Persistent Occiput Posterior or Transverse Position.  J Matern Fetal Neonatal Med. 2011;24;65-72.
15)    Cheng YW, Shaffer BL, Bianco YK, Caughey AB. Timing of operative vaginal delivery and associated perinatal outcomes in nulliparous women. J Matern Fetal Neonatal Med 2011;24:692-7.
16)    Kuppermann M, Nakagawa S, Cohen AR, Dominguez-Pareto I, Shaffer BL, Holloway SD. Attitudes toward prenatal testing and pregnancy termination among a diverse population of parents of children with intellectual disabilities. Prenat Diagn. 2011;31:1251-8.
17)    Kerns JL, Swanson M, Pena S, Wu D, Shaffer BL, Tran SH. Steinauer JE. Characteristics of women who undergo second-trimester abortion in the setting of fetal anomaly. Contraception. 2012;85:63-8. 
18)    Cheng YW, Shaffer BL, Nicholson JM, Caughey AB. Second stage of labor and epidural use: a larger effect than previously suggested. Obstet Gynecol. 2014;123:527-35.
19)    Esakoff TF, Cheng YW, Snowden JM, Tran SH, Shaffer BL, Caughey AB. Velamentous cord insertion: is it associated with adverse perinatal outcomes? J Matern Fetal Neonatal Med. 2014 May 27:1-4
20)    Delaney S, Shaffer BL, Cheng YW, Vargas J, Sparks TN, Paul K, Caughey AB. Predictors of cesarean delivery in women undergoing labor induction with a Foley balloon. J Matern Fetal Neonatal Med. 2014 Jul 31:1-5.
21)    Lo JO, Shaffer BL, Feist CD, Caughey AB. Chromosomal microarray analysis and prenatal diagnosis. Obstet Gynecol Surv. 2014 Oct;69(10):613-21.
22)    Lo JO, Shaffer BL, Allen A, Little SE, Cheng YW, Caughey AB. Intrahepatic cholestasis of pregnancy and timing of delivery.  J Matern Fetal Neonatal Med. 2014 Nov 5:1-20.
23)    Meyer MR, Shaffer BL, Doss AE, Cahill AG, Snowden JH, Caughey AB. Prospective risk of fetal death with gastroschisis. J Matern Fetal Neonatal Med. 2014 Dec 23:1-4.
24)    Lee VR, Pilliod RA, Frias AE, Rasanen JP, Shaffer BL, Caughey AB. When is the optimal time to deliver late preterm IUGR fetuses with abnormal umbilical artery Dopplers?  J Matern Fetal Neonatal Med. 2015 Mar 10:1-6.
25)    Puljic A, Kim E, Page J, Esakoff T, Shaffer BL, LaCoursiere DY, Caughey AB. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2015 May 212:630-632.
26)    Sparks TN, Griffin E, Page J, Pilliod R, Shaffer BL, Caughey AB. Down syndrome: perinatal mortality risks with each additional week of expectant management. Prenat Diagn. 2016 Feb 36:1–7. 
27)    Dotters-Katz SK, Humphrey WM, Senz KL, Lee VR, Shaffer BL, Caughey AB. The Effects of Turner Syndrome, 45,X on Obstetric and Neonatal Outcomes: A Retrospective Cohort Evaluation. Am J Perinatol. 2016 Epub ahead of Print
28)    Dotters-Katz SK, Humphrey WM, Senz KL, Lee VR, Shaffer BL, Caughey AB. The impact of prenatally diagnosed Klinefelter Syndrome on obstetric and neonatal outcomes. Eur J Obstet Gynecol Reprod Biol. 2016 Jun 203:173-176.
29)    Sparks TN, Shaffer BL, Page J, Caughey AB. Gastroschisis: Mortality risks with each additional week of expectant management. Am J Obstet Gynecol 2017 Jan 216:66.e1-7.
30)    Dotters-Katz SK, Humphrey WM, Senz KL, Lee VR, Shaffer BL, Kuller JA, Caughey AB. Trisomy 13 and the risk of gestational hypertensive disorders: a population-based study. J Matern Fetal Neonatal Med 2017 Jun 2:1-5
31)    Bullard KA, Shaffer BL, Greiner KS, Skeith AE, Rodriguez MI, Caughey AB. Twenty-Week Abortion Bans on Pregnancies With a Congenital Diaphragmatic Hernia: A Cost-Effectiveness Analysis. Obstet Gynecol 2018;131:581-90. 
32)    Pilliod RA, Pettersson DR, Gibson T, Gievers L, Kim A, Sohaey R, Oh KY, Shaffer BL. Diagnostic accuracy and clinical outcomes associated with prenatal diagnosis of fetal absent cavum septi pellucidi. Prenat Diagn 2018;38:395-401. https://doi.org/10.1002/pd.5247
33)    Oh KA, Gibson TJ, Pinter J, Pettersson D, Shaffer BL, Selden NR, Sohaey R. Clinical Outcomes Following Prenatal Diagnosis of Asymmetric Ventriculomegaly, Interhemispheric Cyst, and Callosal Dysgenesis (AVID). Prenatal Diagnosis. 2019;39:26-32. https://doi.org/10.1002/pd.5393
34)    Avram CM, Shaffer BL, Sparks TN, Allen AJ, Caughey AB. Cell-free fetal DNA screening for detection of microdeletion syndromes: a cost effectiveness analysis. J Matern Fetal Neonatal Med 2019. https://doi.org/10.1080/14767058.2019.1647161
35)    Bak GS, Shaffer BL, Madriago E, Allen A, Kelly B, Caughey AB, Pereira L. Impact of maternal obesity on fetal cardiac screening: which follow-up strategy is cost-effective? Ultrasound Obstet Gynecol 2019 Oct 15.  doi: 10.1002/uog.21895.PMID: 31614030
36)    Bak GS, Shaffer BL, Madriago E, Allen A, Kelly B, Caughey AB, Pereira L. Detection of fetal cardiac anomalies: is increasing the number of cardiac views cost-effective? Ultrasound Obstet Gynecol. 2020 Jan 16. https:doi: 10.1002/uog.21977. PMID: 31945242
37)    Hacker FM, Hersh AR, Shaffer BL. Caughey AB. Isolated Echogenic Intracardiac Foci and the role of cell free fetal DNA: A Cost Effectiveness Analysis. Prenatal Diagn 2020 July 27. https://doi: 10.1002/pd.5803.
38)    Consumer Testing for Disease Risk. ACOG Committee Opinion No 816. American College of Obstetricians and Gynecologists 2021;137:e1-e6. doi: 10.1097/AOG.0000000000004200
39)    Avram CM, Dyer AL, Shaffer BL, Caughey AB. The cost-effectiveness of genotyping versus sequencing for prenatal cystic fibrosis carrier screening. Prenat Diagn 2021 October 4. PMID: 34346064 DOI: 10.1002/pd.6027
40)    Kim AJH, Servino L, Bircher S, Rdesinski R, Dukhovny S, Shaffer BL, Saxton S. Depression and socioeconomic stressors in expectant parents with fetal congenital anomalies. J Matern Fetal Neonatal Med. 2021 https:// 10.1080/14767058.2021.1992379.

Case reports
1)    Lo JO, Feist CD, Hashima J, Shaffer BL. Jacobsen syndrome detected by prenatal testing. Obstet Gynecol. 2015 Feb 125:387-389.
2)    Yieh L, Ramo C, Feist C., Shaffer BL, Kim A. Monozygotic Dichorionic Diamniotic Twins with Large Interstitial Deletion of Chromosome 1p. Clin Case Rep 2019;6-1735-40.  DOI:10.1002/ccr3.2358

Non-peer-reviewed
Books
1)    Filbin M, Lee L, Shaffer BL, Caughey AB. Blueprints Pathophysiology II - Pulmonary, Gastrointestinal, and Rheumatology: Notes and Cases. Waltham: Blackwell Publishing, 2003
2)    Woodward, Kennedy, Byrne, Puchalski, Shaffer, Hogan, Jha, Edwards. Diagnostic Imaging: Obstetrics, 4th edition. Philadelphia, Elsevier 2021

Chapters
1)    Borer JS and Shaffer BL. Chapter 7 “Edema and Foot Injuries: Pathophysiology and Differential Diagnosis.” In Ranawat CS, Positano RG (eds.): Disorders of the Heel, Rearfoot, and Ankle. New York, Churchill Livingstone, 1999.
2)    Shaffer BL and Parer JT. Chapter 11 “Antepartum fetal monitoring.” In Queenan JT, Spong CY, Lockwood CJ (eds.): Management of High Risk Pregnancy, 5th edition. Malden MA, Blackwell, 2007.
3)    Shaffer BL and Rauen KR. “Reproductive Genetics.” In DiSaia P, Chaudhuri G, Giudice L, Moore T, Porto M, Smith L (eds.). The University of California Obstetrics and Gynecology Women’s Health Review.   2012.

Reviews
1)    Chetty SP, Shaffer BL, Norton ME.  Management of pregnancy in women with genetic disorders: part 1: Disorders of the connective tissue, muscle, vascular, and skeletal systems. Obstet Gynecol Surv. 2011;66:699-709.
2)    Chetty SP, Shaffer BL, Norton ME.  Management of pregnancy in women with genetic disorders: part 2: inborn errors of metabolism, cystic fibrosis, neurofibromatosis type 1, and turner syndrome in pregnancy. Obstet Gynecol Surv. 2011;66:765-76.
3)    Shaffer BL Norton ME. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes. Obstet Gynecol Clin North Am 2018;45:13-26.

Abstracts
1)    Avram CM, Shaffer BL, Caughey AB. Ultrasound as a second screen after positive cell free fetal DNA for trisomy 21: A cost effectiveness analysis. Am J Obstet Gynecol 2020;222:S240
2)    Dyer AL, Avram AM, Shaffer BL, Caughey AB. Carrier screening with sequencing vs. genotyping for cystic fibrosis: A cost effectiveness analysis. Am J Obstet Gynecol 2020;222:S506
3)    Allen A, Shaffer BL, Caughey AB, Pilliod RA. Nuchal translucency ultrasound in women with low risk cell free fetal DNA screening: A cost effectiveness analysis. Am J Obstet Gynecol 2020;222:S517
4)    Bullard KA, Shaffer BL, Greiner KS, Rodriguez MI, Caughey AB. Impact of twenty-week abortion bans on Down Syndrome: a cost effectiveness analysis. Am J Obstet Gynecol 2019;220:S227.
5)    Avram CM, Shaffer BL, Sparks TN, Allen AJ, CaugheyAB. Cell free fetal DNA screening for detection of microdeletion syndromes: A cost-effectiveness analysis. Am J Obstet Gynecol 2019;220:S885.
6)    Bullard KA, Pilliod RA, Shaffer BL, Rodriguez MI, Caughey AB. Impact of twenty week abortion bans in the setting of prenatal diagnoses: cost effective analysis. Am J Obstet Gynecol 2019;220:S895.
7)    Kim A, Feist C, Padilla T, Dukhovny S, Shaffer BL, Dukhovny D. Yield of genetic testing in fetuses and neonates with congenital heart disease. Pediatric Academic Society Meeting 2018
8)    Allen AA, Shaffer BL, Avram CM, Caughey AB. Cell freee DNA screening for single gene disorders: A cost effectiveness analysis. Am J Obstet Gynecol 2017;218:S170.
9)    Hoffman SW, Zwerling B, Shaffer BL, Cahill AG, Caughey AB. Fetal scalp lactate and digital scalp stimulation among those with non-reassuring fetal heart rate tracings: A decision analytic model. Am J Obstet Gynecol 2017;218:S182.
10)    Hacker FH, Griffin EG, Shaffer BL, Caughey AB. Isolated echogenic intracardiac foci and the role of cell free fetal DNA. Am J Obstet Gynecol 2017;218:S280.
11)    Avram CM, Allen AA, Shaffer BL, Caughey AB. The impact of Prader Willi Syndrome on perinatal outcomes. Am J Obstet Gynecol 2017;218:S288.
12)    Avram CM, Allen AA, Shaffer BL, Caughey AB. The impact of 22q11.2 Deletion Syndrome on neonatal outcomes. Am J Obstet Gynecol 2017;218:S289.
13)    Bullard KA, Shaffer BL, Scrivner KJ, Sharshiner R, Rodriguez MI, Caughey AB. Impact of 20 week abortion bans on the prenatal diagnosis of hypoplastic left heart syndrome: A cost effectiveness analysis. Am J Obstet Gynecol 2017;218:S290.
14)    Humphrey WM, Griffin EE, Senz KL, Shaffer BL, Caughey AB. Routine amniocentesis versus serum screening for detection of aneuploidy in women of advanced maternal age. Am J Obstet Gynecol 2016;214:S82.
15)    Humphrey WM, Senz KL, Lee VR, Shaffer BL, Caughey AB. The impact of 45,X on perinatal outcomes. Am J Obstet Gynecol 2016;214:S83.
16)    Humphrey WM, Griffin EE, Lee VR, Ameel BM, Shaffer BL, Caughey AB. What is the best clinical approach after a non-invasive prenatal testing test failure in women with low risk for aneuploidy. Am J Obstet Gynecol 2016;214:S83.
17)    Fields AK, Bak G, Senz KL, Lee VR, Shaffer BL, Caughey AB. Optimal gestational age at delivery for pregnancies with fetal cardiac anomalies: a decision analysis. Am J Obstet Gynecol 2016;214:S102.
18)    Lai J, Niu B, Shaffer BL, Caughey AB. Is tranexamic acid use associated with better maternal outcomes in routine cesarean? A cost effectiveness analysis. Am J Obstet Gynecol 2016;214:S111.
19)    Kernberg A, Sparks T, Shaffer BL, Burwick R, Caughey AB. Congenital anomalies in twin versus triplet pregnancies. Am J Obstet Gynecol 2016;214:S163-4.
20)    Humphrey WM, Griffin EE, Shaffer BL, Caughey AB. Microarray versus karyotype for pregnant women with anomalies found on ultrasonography. Am J Obstet Gynecol 2016;214:S182-3.
21)    Humphrey WM, Griffin EE, Lee VR, Aviram A, Shaffer BL, Caughey AB. Routine amniocentesis versus standard serum screening for detection of aneuploidy in women in a low-risk population. Am J Obstet Gynecol 2016;214:S251.
22)    Humphrey WM, Griffin EE, Lee VR, Aviram A, Shaffer BL, Caughey AB. What is the best clinical approach after a non0invasive prenatal testing test failure in women at high risk for aneuploidy? Am J Obstet Gynecol 2016;214:S252.
23)    Humphrey WM, Senz KL, Lee VR, Shaffer BL, Caughey AB. The impact of 47,XXY on perinatal outcomes. Am J Obstet Gynecol 2016;214:S252.
24)    Senz KL, Humphrey WM, Lee VR, Shaffer BL, Caughey AB. The impact of trisomy 13 on perinatal   outcomes. Am J Obstet Gynecol 2016;214:S400-1.
25)    Puljic A, Kim E, Page J, Esakoff T, Shaffer BL, Lacoursiere D, Caughey AB. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy stratified by gestational age. Am J Obstet Gynecol 2015;212:S52.
26)    Hacker F, Griffin E, Shaffer BL, Caughey AB. Role of genetic sonogram and NIPT after EIF detection: a cost effectiveness analysis. Am J Obstet Gynecol 2015;212:S171.
27)    Fields A, Griffin E, Sparks T, Pilliod R, Shaffer BL, Caughey AB. Mortality risk of common cardiac anomalies in Down syndrome. Am J Obstet Gynecol 2015;212:S227.
28)    Puljic A, Kim E, Esakoff T, Lacoursiere D, Shaffer BL, Caughey AB. Maternal pregnancy complications associated with intrahepatic cholestasis of pregnancy in a population based cohort. Am J Obstet Gynecol 2015;212:S261.
29)    Sparks T, Shaffer BL, Page J, Caughey AB. Gastroschisis” what is the risk of fetal demise and infant death with each additional week of expectant management? Am J Obstet Gynecol 2015;212:S278.
30)    Sparks T, Griffin E, Page J, Fields A, Shaffer BL, Caughey AB. Down syndrome: what are the risks of stillbirth and adverse neonatal outcomes? Am J Obstet Gynecol 2015;212:S349.
31)    Lee V, Burwick R, Pilliod R, Shaffer BL, Cheng YW, Caughey AB. Outcomes in late preterm pregnancies complicated by gestational diabetes mellitus and polyhydramnios. Am J Obstet Gynecol 2015;212:S352.
32)    Pilliod R, Madriago E, Minette M, Fields A, Caughey AB, Shaffer BL. Incidence of perinatal and infant death in a large cohort with congenital cardiac disease. Am J Obstet Gynecol 2015;212:S410.
33)    Lee V, Burwick R, Pilliod R, Shaffer BL, Cheng YW, Caughey AB. Outcomes of term pregnancies complicated by gestational diabetes mellitus and polyhydramnios. Am J Obstet Gynecol 2015;212:S420.
34)    Shaffer BL, Chan J M, Doss AE, Lim J, Sohaey R, Oh KY. Prenatal Diagnosis of Fetal Hydronephrosis: Inter-rater reliability of the A-P diameter versus the Society of Fetal Urology (SFU) grading system.  AIUM 2014 Las Vegas. 
35)    Pettersson DR, Yutan E, Shaffer BL, Sohaey R, Oh KY. The subtle signs of holoprosencephaly - how to avoid under diagnosis on fetal ultrasound. AIUM 2014, Las Vegas.
36)    Oh KY, Shaffer BL, Lo J, Bardo DM, Sohaey R. Fetal masses: Key imaging findings which determine in utero management and delivery planning. Accepted as CME exhibit and awarded Certificate of Merit, RSNA 2013, Educational exhibit.
37)    Shaffer BL, Doss A, Yanit K, Cheng YW, Cahill A, Snowden J, Caughey AB. Prospective risk of fetal death in gastroschisis. Am J Obstet Gynecol 2013;208:S180.
38)    Ohno M, Allen A, Cheng YW, Shaffer BL,  Blumenfeld Y, Norton ME, Caughey AB.  A cost-effectiveness analysis of using non-invasive prenatal testing as a screening tool for Down syndrome. Am J Obstet Gynecol 2013;208:S235.
39)    Doss A, Yanit K, Allen A, Shaffer BL, Cheng YW, Caughey AB. What is the optimal GA to deliver dichorionic diamniotic twins when one twin has a major cardiac anomaly? Am J Obstet Gynecol 2013;208:S55.
40)    Cheng YW, Shaffer BL, Caughey AB. The second stage of labor and persistent occiput posterior position: patience or intervention? Am J Obstet Gynecol 2013;208:S152.
41)    Fowler J, Allen A, Emerson J, Page J, Shaffer BL, Cheng YW Caughey AB. Optimal timing of delivery in women with prior stillbirth: a decision analysis. Am J Obstet Gynecol 2013;208:S64.
42)    Marshall N, Emerson J, Allen A, Tolosa J, Wyatt S, Pereira L, Shaffer BL, Caughey AB. Obstetric ultrasound in obese women: is routine transvaginal ultrasound cost effective? Am J Obstet Gynecol 2013;208:S167.
43)    Shaffer BL, Pilliod RA, Ames MA, Caughey AB. Fetal Gastroschisis: What is the optimal gestational age for delivery?  Am J Obstet Gynecol 2012;206:S336.
44)     Esakoff TF, Cheng YW, Snowden J, Tran SH, Shaffer BL, Caughey AB. Velamentous cord insertion: does it affect Perinatal outcomes? Am J Obstet Gynecol 2012;206:S21.
45)    Pilliod RA, Doss AE, Snowden J, Cheng YW, Page JM, Shaffer BL, Caughey AB. Small for gestational age cohort – Risk of IUFD. Am J Obstet Gynecol 2012;206:S77.
46)    Little S, Sparks TN, Pilliod R, Shaffer BL, Caughey AB, Kaimal A. What is the optimal time to deliver dichorionic diamniotic twins? Am J Obstet Gynecol 2012;206:S78. 
47)    Sparks TN, Little S, Pilliod R, Shaffer BL, Kaimal A, Caughey AB. What is the optimal time to deliver monochorionic diamniotic twins? Am J Obstet Gynecol 2012;206:S81.
48)    Cahill AG, Pilliod R, Odibo A, Shaffer BL, Caughey AB. Cost effectiveness of open fetal surgery for fetal myelomeningocele (MMC). Am J Obstet Gynecol 2012;206:S185.
49)    Pilliod RA, Doss AE, Snowden J, Cheng YW, Page J, Shaffer BL, Caughey AB. Optimal timing of delivery for the small for gestational age fetus: a decision analysis. Am J Obstet Gynecol 2012;206:S283.
50)    Delaney S, Shaffer BL, Cheng YW, Vargas JE, Sparks T, Paul K, Caughey AB. Predictors of cesarean delivery in women undergoing labor induction with a foley balloon. Am J Obstet Gynecol 2011;204:S78.
51)    Cheng YW, Shaffer BL, Stasenko M, Caughey AB. Women with gestational diabetes mellitus: induction or spontaneous labor? Am J Obstet Gynecol 2011;204:S119.
52)    Salmeen K, Cheng YW, Shaffer BL, Nicholson J, Caughey AB. Induction of labor and VBAC success rates: What is the role of gestational age? Am J Obstet Gynecol 2011;204:S128-9.
53)    Delaney S, Shaffer BL, Cheng YW, Vargas JE, Sparks T, Paul K, Caughey AB. Labor induction with a foley balloon trial (LIFT) – a randomized controlled trial of 30mL versus 60mL Foley balloon inflation. Am J Obstet Gynecol 2009;201:S23-4.
54)    Cheng YW, Nicholson J, Shaffer BL, Lyell D, Caughey AB. The second stage of labor and epidural use: a larger effect than previously suggested. Am J Obstet Gynecol 2009;201:S46.
55)    Cheng YW, Shaffer BL, Kaimal AK, Caughey AB. Twin gestations at periviable gestational age: Two worse than one? Am J Obstet Gynecol 2009;201:S199.
56)    Herrick C, Cheng YW, Shaffer BL, Caughey AB. Fetal position, fetal weight, and mode of delivery. Am J Obstet Gynecol 2009;201:S222-223.
57)    Caughey AB, Shaffer BL, Nicholson JM, Nakagawa S, Cheng YW. Perinatal asyphxia: Does obstetric volume matter? Am J Obstet Gynecol 2009;201:S224.
58)    Shaffer BL, Cheng YW, Laros RK, Caughey AB. Operative vaginal delivery by fetal position and station: Are forceps less likely to fail?  Am J Obstet Gynecol 2009;201:S248.
59)    Shaffer BL, Tran S, Norton ME, Malabed K, Pena S, Caughey AB. Amniocentesis based on the potential for significant chromosomal abnormalities: A decision analysis. Am J Obstet Gynecol 2008;199:S185.
60)    Tran S, Shaffer BL, Norton ME, Malabed K, Pena S, Caughey AB. Prenatal array comparative genomic hybridization analysis amongst women choosing invasive prenatal diagnosis: A decision analysis. Am J Obstet Gynecol 2008;199:S163.
61)    Solheim K, Myers D, Sparks T, Shaffer BL, Cheng Y, Caughey A. Continuing a trial of labor after 2 hours of active phase arrest: A cost-effectiveness analysis. Am J Obstet Gynecol 2008;199:S68.
62)    Shaffer BL, Shankar S, Nicholas E, Weisiger K, Zlatunich C, O’Brien W, Kang SM, Ferrell L, Kim G, Rosenthal P, Packman S. Orthotopic liver transplant for Arginase deficiency. Am J of Hum Genet 2008;S178.
63)    Kaimal A, Little S, Shaffer BL, Cheng Y, Zlatnik MG, Caughey AB. Cost-effectiveness of antenatal steroids for preterm labor at 34 weeks. Am J Obstet Gynecol 2007;197:S91.
64)    Cheng YW, Bianco YK, Shaffer BL, Lyell D, Caughey AB. Operative Vaginal Delivery: Now or later? Am J Obstet Gynecol 2007;197:S313.
65)    Myers D, Cheng Y, Kaimal A, Shaffer BL, Caughey AB. Active Phase Arrest: Perinatal outcomes in vaginal versus cesarean deliveries. Am J Obstet Gynecol 2007;197:S329.
66)    Myers D, Tran N, Cheng Y, Kaimal A, Shaffer BL, Caughey AB. Active phase Arrest: The effect of arrest duration in mode of delivery. Am J Obstet Gynecol 2007;197:S330.
67)    Bianco YK, Cheng Y, Shaffer BL, Lyell D, Caughey AB. Cesarean delivery during the second stage of labor: Is timing associated with perinatal outcomes? Am J Obstet Gynecol 2007;197:S332.
68)    Child A, Cheng YW, Shaffer BL, Kaimal A, Little S, Caughey AB. Early onset pre-eclampsia and neonatal outcomes. Am J Obstet Gynecol 2007;197:S473.
69)    Shaffer BL, Cheng YW, Vargas JE, Laros RK, Caughey AB.  Comparing Manual, Forceps, and Vacuum Rotations for Occiput posterior and Transverse Position. Am J Obstet Gynecol 2006;195:S97.
70)    Shaffer BL, Cheng YW, Caughey AB.  Midpelvic Deliveries: What is the Association Between Mode of Delivery and Perinatal Outcomes? Am J Obstet Gynecol 2006;195:S86.
71)    Shaffer BL, Cheng YW, Caughey AB. Operative Vaginal Deliveries: What is the Association Between Station and Perinatal Outcomes? Am J Obstet Gynecol 2006;195:S87.
72)    Bianco K, Cheng YW, Shaffer BL, Norton ME, Lyell DJ, Caughey AB. Successful operative vaginal deliveries in women with prolonged second stage: Is it worth the wait? Am J Obstet Gynecol 2006;195:S101.
73)    Myers D, Cheng YW, Shaffer BL, Kaimal A, Bianco K, Caughey AB.  Active Phase Arrest: Who will Deliver Vaginally? Am J Obstet Gynecol 2006;195:S91.
74)    Shaffer BL, Little SE, Cheng YW, Vargas JE, Caughey AB. Intrahepatic Cholestasis of Pregnancy: What is the Optimal Gestational age for Delivery? Am J Obstet Gynecol 2006;195:S225.
75)    Tran SH, Shaffer BL, Cheng YW, Aziz N, Thiet MP, Caughey AB. Length of rupture of membranes at term and infectious maternal outcomes. Am J Obstet Gynecol 2005;193:S691
76)    Shaffer BL, Cheng YW, Vargas JE, Laros Jr RK, Caughey AB. Manual Rotation of the Fetal Occiput: Predictors of Success and Delivery. Am J Obstet Gynecol 2005;193:S22
77)    Bianco K, Tran SH, Cheng YW, Norton ME, Shaffer BL, Caughey AB. Perinatal outcomes in women with a history of spontaneous abortions. Am J Obstet Gynecol 2005;193:S106
78)    Shaffer BL, Cheng YW, Caughey AB. Manual rotation of the fetal occiput in persistent transverse or posterior position. Obstet Gynecol 2005;105:78S
79)    Cheng YW, Shaffer BL, Caughey AB. Predictors and Complications Associated with Occiput Posterior Position. Am J Obstet Gynecol 2004;191:S185
80)    Shaffer BL, Caughey AB, Norton ME. Pregnancy outcomes in the setting of atypical fetal aneuploidy. Am J of Hum Genetics 2004;S2756.
81)    Shaffer BL, Caughey AB, Norton ME. Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Am J Obstet Gynecol 2004;189:S112.
82)    Shaffer BL, Cotter PH, Caughey AB, Norton ME. Application of Comparative Genomic Hybridization using Microarrays to Routine Prenatal Diagnosis. Am J of Hum Genet 2003;73:S601.
 
Invited Lectures, Conference Presentations or Professorships:
International and National:
SMFM Postgraduate Lecture in “Prenatal Genetics for the MFM Physician in 2022 and Beyond” Lecture, “Diagnostic Testing Options Overview” 2/4/2022
American College of Medical Genetics (ACMG) Annual Meeting short course, “What’s in a Panel A Decade of Expanded Carrier Screening in Review – A clinician’s perspective” April 16, 2021.
Society of Maternal Fetal Medicine (SMFM), Post Graduate Course Co-Director, “Prenatal Genetics: Application of New Technologies” 2/5/2020.
SMFM Postgraduate Lecture in “Prenatal Genetics: Application of New Technologies” Lecture, “Update on Expanded Carrier Screening” 2/5/2020.
Society of Maternal Fetal Medicine (SMFM), Post Graduate Course Co-Director, “Prenatal Genetics: Tools for Today and the Ever Expanding Genomic Horizon” 1/23/2017.
SMFM Postgraduate Course: “Prenatal Genetics: Tools for Today and the Ever Expanding Genomic Horizon” 1/23/2017. Lecture: “Non-Mendelian Genetics” 
SMFM Postgraduate Course: “Prenatal Genetics: Tools for Today and the Ever Expanding Genomic Horizon” 1/23/2017. “Variant of Uncertain significance of Chromosomal Microarray – Work-up” 
American College of Obstetrics and Gynecology (ACOG) Annual Meeting, 5/14/2016. “Hands On Course: Essential Skills for Safe Forceps Assisted Vaginal Deliveries” – Course Faculty Member. 
Society of Maternal Fetal Medicine (SMFM) Annual Meeting, 2/3/2016. “Prenatal Genetics Updates: RASopathies, Whole exome sequencing, and cell free fetal DNA” Forum Co-Leader.
Society of Maternal Fetal Medicine (SMFM) Annual Meeting, 2/4/2015. “Genetics Forum on ‘Updates in Non-Invasive Prenatal Testing” Seminar Co-Leader.
American College of Medical Genetics (ACMG) Short Course, “Arrays, NIPT and Expanded Carrier Screening: Advances and Controversies in Prenatal Genetics” 3/19/2013 Course Co-Director; Lecture: “Expanded Carrier Screening – A Debate” 
American College of Medical Genetics (ACMG) Short Course, “Arrays, NIPT and Expanded Carrier Screening: Advances and Controversies in Prenatal Genetics” 3/19/201; Course Co-Director; Lecture: “Putting it all together – Clinical case scenarios”
Society of Maternal Fetal Medicine (SMFM), Post Graduate Course Co-Director, “Prenatal Genetics Out with the Old, In with the New” 2/13/2013.
SMFM Postgraduate Course: “Prenatal Genetics Out with the Old, In with the New” 2/13/2013. “Expanded carrier screening – Why bother?” 
SMFM Postgraduate Course: “Prenatal Genetics Out with the Old, In with the New” 2/13/2013. “Putting it all together – Clinical scenarios?” 
Society of Maternal Fetal Medicine, Oral Platform; Miami FL, 2006, “Manual Rotation of the Fetal Occiput: Predictors of Success and Delivery” 

Regional and Local: 
UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, June 2022, “Common Ultrasound Findings: When to Worry” and “Fetal Heart Rate Monitoring Interactive Session with Faculty Panel”

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; San Antonio, TX; January 2022, “Genetics of Fetal Anomalies: Tips and Pearls”,  “Panel Discussion: Education, Learning and New Protocols in Clinical Practice of Fetal Ultrasound”, “Amniotic Fluid Abnormalities: Tips and Pearls” and “Abdominal Wall Defects: Tips and Pearls” 

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, June 2021, “Family history: ”How, Why, When?” and  “Fetal Heart Rate Monitoring Interactive Session with Faculty Panel” 

Sutter Santa Rosa – Grand Rounds; Santa Rosa, CA. 1/21/2021 “Prenatal Genetic Screening and Diagnosis” 

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA-Virtual; September 2020, “Fetal Genital Anomalies and Considerations: What to do with discordant cf DNA”,  “Genetics of Fetal Anomalies: Special Cases”, and “Fetal Well-being: Amniotic Fluid and BPP” 

OHSU Department of Molecular and Medical Genetics, Grand Rounds; Portland, Oregon, March 2020, “A Practical Prenatal Approach to Disorders of Sex Differentiation (DSD)”

Legacy Randall Children’s Hospital at Legacy Emanuel – Department of Pediatrics Grand Rounds; Portland, OR; January 2020, “A Practical Prenatal Approach to Disorders of Differentiation (DSD)”

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA; September 2019, “Abdominal Wall Defects”, Abnormalities of Amniotic Fluid: Too much, too Little” and “A practical Approach to Disorders of Sex Differentiation (DSD)” 

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, June 2019,” Update on Fetal Growth Restriction” and “Fetal Heart Rate Monitoring Interactive Session with Faculty Panel” 

University of Hawai’i John Burns School of Medicine Department of Obstetrics and Gynecology – Community Collaborations: Obstetrics, Genetics and Ultrasound; Honolulu Hawai’i, December 2018, “Direct to Consumer: Expanded Carrier Screening”, “When and How to use Microarray Analysis and Prenatal Diagnosis” and “Unusual Abdominal Wall Defects”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, June 2018,”Category II Tracings: Does Fetal Resuscitation Work?” and “Fetal Heart Rate Monitoring Interactive Session with Faculty Panel”

Pacific Coast Obstetrical and Gynecological Society, Annual Meeting; Palm Desert CA; November 2017, “Prenatal Diagnosis of Fetal Hydronephrosis: Inter-rater reliability of the AP diameter versus the Society of Fetal Urology (SFU) grading system and application to Urinary Tract Dilatation (UTD) classification” 

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA; September 2017, “CLEAR (Cervical Length Education and Review Program) Why, Why to Get Certified, & Technique” and “Oli and Poly: Update on Fluid”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, June 2017,”Antenatal Testing: Who, When How?” and “Fetal Heart Rate Monitoring Interactive Session with Faculty Panel”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences – Grand Rounds; San Francisco, CA, September 2016; “The Continued Expansion of Prenatal Diagnosis: Victories and Headaches” 

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, June 2016,”Persistent OP - Is Manual Rotation the Answer?”  

OHSU Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Northwest Update; Portland OR; November 2015, “Cell free fetal DNA (cfDNA): A Debate!”

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA; September 2015, “Fetal Sex Anomalies: Imaging, Genetic Diagnosis, and Management”

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA; September 2015, “Genetic Basis of Fetal Anomalies: What’s New?”

OHSU Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Northwest Update; Portland OR; November 2014, “Non-invasive Prenatal Diagnosis (NIPT) with cell free fetal DNA (cfDNA): Breaking News”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, June 2014,” Genetic Carrier Screening: Review of the Old, the New, and the Controversial”  

OHSU Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Northwest Update; Portland OR; November 2013, “Hot Topic: Prenatal/Postnatal Diagnosis: Best Practices & Human Rights”

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA; September 2013, “Fetal Genitalia-Is it Ambiguous”

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA; September 2013, “Understanding the new Genetic Tests: Microarrays and Cell free fetal DNA”

OHSU Department of Pediatrics CME Course – 8th Annual Pediatric Review and Update; Portland OR; May 16, 2013, “Hot Topic Review: Antenatal Hydronephrosis – Views from the Radiologist, Perinatologist and the Urologist”

Good Samaritan Regional Health Center – Hospital Grand Rounds; Corvallis OR; January 2013 “Multidisciplinary Fetal Care: Optimizing outcomes for the fetus with a major anomaly”

Northern California Obstetrical and Gynecological Society – Annual Symposium; Sacramento CA; November 2012, “Screening for aneuploidy – Time for a new test? Non-Invasive Prenatal Testing (NIPT) using cell free fetal DNA”

Northern California Obstetrical and Gynecological Society – Annual Symposium; Sacramento CA; November 2012, “Use of array CGH in Prenatal Diagnosis”

OHSU Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Northwest Update; Portland OR; November 2012, “Noninvasive Fetal Detection of Aneuploidy in Maternal Serum using cell free fetal DNA (cf DNA)”

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA; September 2012, “Genetic Basis of Fetal Anomalies – What’s New?”

World class CME. Fetal and Women’s Imaging Course – Advanced Ob/Gyn Ultrasound; Seattle WA; September 2012, “Invasive Prenatal Diagnosis”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, 2012,”Microarrays: What do they Add?”  

American Congress of Obstetrics and Gynecologists (ACOG), Oregon Section, 20th Annual Clinical Meeting: Sunriver OR, 2012 “Prenatal Diagnosis and Screening – An update”

American Congress of Obstetrics and Gynecologists (ACOG), Oregon Section, 20th Annual Clinical Meeting: Sunriver OR, 2012 “To Mag or not to Mag: A debate”

OHSU Department of Obstetrics and Gynecology, Grand Rounds: Portland OR, 2011 “Use of array CGH in Prenatal Diagnosis”

Legacy-Emmanuel Department of Obstetrics and Gynecology, Grand Rounds: Portland OR, 2011 “Use of Microarray CGH in Obstetrics”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course - What does the Evidence Tell Us? San Francisco CA, 2010, ”Nuances of prenatal genetic screening” 

California Pacific Medical Center, Department of Obstetrics and Gynecology Grand Rounds; San Francisco, CA 2010, “Manual Rotation to Reduce Cesarean Delivery in Persistent Occiput Posterior and Transverse Position”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course - What does the Evidence Tell Us? San Francisco CA, 2009, ”Update on California State Prenatal Screening Program” 

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course – Antepartum and Intrapartum Management (AIM); San Francisco CA, 2009,”OP and OT Can We Turn It Around?”  

UCSF Department of Pediatrics Grand Rounds; San Francisco, CA; 2009 “Prenatal Diagnosis: Past, Present, and Future”

Pacific Coast Obstetrical and Gynecological Society, Frank Lynch Memorial Essayist, Victoria, British Columbia, 2008, “Manual Rotation to Reduce Cesarean Delivery in Persistent Occiput Posterior or Transverse Position”
    
UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME Course - What does the Evidence Tell Us? San Francisco CA, 2008, ”Update on Prenatal Genetics” 

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences, Grand Rounds; San Francisco, CA 2008, “Intrapartum Fetal Resuscitation, A misnomer?”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME course - Antepartum and Intrapartum Management; San Francisco CA, 2007 “Intrapartum Fetal Resuscitation, A misnomer?”

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences CME course - Antepartum and Intrapartum Management; San Francisco CA, 2006, “The Current State of Antepartum Surveillance” 

UCSF Department of Obstetrics, Gynecology and Reproductive Sciences, Resident Research Day; San Francisco, CA, 2004, “Application of Comparative Genomic Hybridization Using Microarrays to Routine Prenatal Diagnosis”

Research Awards
American Journal of Obstetrics and Gynecology (AJOG) Research Excellence Award for the paper entitled, “The risk of infant and fetal death by each week of expectant management in intrahepatic cholestasis of pregnancy by gestational age”. The award is presented to the authors for a work presented at the annual SMFM meeting and published in AJOG with the top number of citations.

Prenatal Diagnosis Award for the top 10% most downloaded papers (January 2018-December 2019) for the paper entitled “Clinical outcomes following prenatal diagnosis of asymmetric ventriculomegaly, interhemispheric cyst, and callosal dysgenesis (AVID)”

V.  SERVICE
 

Membership in Professional Societies:
2019-present    Fellow, American College of Medical Genetics and Genomics (ACMG)
2017-present    Fellow, Pacific Coast Obstetrical and Gynecological Society (PCOGS)
2007-present     Alpha Omega Alpha, Honor Medical Society
2004-present    Society of Maternal Fetal Medicine
2002-present    American Congress of Obstetrics and Gynecology
2011-2016         International Society of Ultrasound in Obstetrics and Gynecology

    APPOINTED OR ELECTED POSITIONS:
2020-Present   Prenatal Diagnosis Center, Director; SWBMG
2018-2020        Program Director, Maternal Fetal Medicine Fellowship & Combined Maternal Fetal
Medicine and Medical Genetics; OHSU
2016-2018       Assistant Program Director, Maternal Fetal Medicine Fellowship, OHSU
2011-2020       Director, Fetal Therapy Program Oregon Health and Sciences University
2012-2020       Director, Prenatal Diagnosis Program, Oregon Health and Sciences University
2011-2017       Member, Obstetrics Quality Executive Committee (QEC), OHSU
    NATIONAL CREDENTIALING ACTIVITIES:
Editorial and Ad Hoc Review Activities:
2005-present    Journal of Perinatology
2005-present    Obstetrics and Gynecology
2016 “Top 10% of Reviewers for Obstetrics and Gynecology” Awarded to top 10% of those based on the number, quality and timeliness of reviews provided.
2014 “Top 10% of Reviewers for Obstetrics and Gynecology” Awarded to top 10% of those based on the number, quality and timeliness of reviews provided.
2006-present    American Journal of Obstetrics & Gynecology 
2008-present    British Journal of Obstetrics and Gynecology
2011-present    Prenatal Diagnosis
2011-present    Genetics in Medicine
2013-present        Acta Obstetricia et Gynecologica Scandinavica (AOGS)
2013-present    Journal of Genetic Counseling

Committees:
National 
2020-2022    Member, American College of Obstetrics and Gynecology Clinical Practice Guidelines, Obstetrics Committee
2018-2020     Member, American College of Obstetrics and Gynecology – Committee on Genetics  

Honors and Awards for Education:
2013    “Best Lecturer” Ob/Gyn Residency OHSU
2012    “Excellence in Obstetrical Teaching” Ob/Gyn Residency OHSU
2011    Outstanding Faculty Medical Student Teaching Award (Obstetrics and Gynecology) UCSF
2008    Outstanding Resident Teaching Award, Dept. Ob/Gyn, UCSF

Educational Conference Presentations: 
Society of Maternal Fetal Medicine 2020, Post Graduate Course: Co-Director and Lecturer
Six-hour course intended to guide MFM Fellows in Training as well as MFM physicians to update on advances in technology and application on prenatal genetics. 

Society of Maternal Fetal Medicine – 2017, Postgraduate course: Course Co-moderator and Lecturer
Six-hour course intended to guide MFM Fellows in Training as well as MFM physicians to update on advances on prenatal genetics. 

Society of Maternal Fetal Medicine (SMFM) – 2015-2016, Role: Scientific Forum: Genetics Group Moderator.  Developed a program and moderated lectures by leaders in field of prenatal diagnosis. Discussion intended to augment learning, provide hands on education, and provide a forum to discuss challenging issues for MFM Fellows and MFM physicians in practice

Society of Maternal Fetal Medicine – 2013, Postgraduate course: Moderator and Lecturer
Five-hour course intended to guide MFM Fellows in Training as well as MFM physicians to update on advances on prenatal genetics. 

American College of Medical Genetics (ACMG) – 2013, Post graduate course: Moderator and Lecturer
Five-hour course intended to guide Geneticists and Genetic counselors in patient care on advances on prenatal genetics.